vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $219.1M, roughly 1.7× Sprinklr, Inc.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs 1.3%, a 1.7% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 9.2%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $19.8M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

CXM vs LFST — Head-to-Head

Bigger by revenue
LFST
LFST
1.7× larger
LFST
$382.2M
$219.1M
CXM
Growing faster (revenue YoY)
LFST
LFST
+8.3% gap
LFST
17.4%
9.2%
CXM
Higher net margin
LFST
LFST
1.7% more per $
LFST
3.1%
1.3%
CXM
More free cash flow
LFST
LFST
$26.9M more FCF
LFST
$46.6M
$19.8M
CXM
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
LFST
LFST
Revenue
$219.1M
$382.2M
Net Profit
$2.9M
$11.7M
Gross Margin
66.4%
Operating Margin
5.3%
4.7%
Net Margin
1.3%
3.1%
Revenue YoY
9.2%
17.4%
Net Profit YoY
-72.2%
264.1%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
LFST
LFST
Q4 25
$219.1M
$382.2M
Q3 25
$212.0M
$363.8M
Q2 25
$205.5M
$345.3M
Q1 25
$202.5M
$333.0M
Q4 24
$200.7M
$325.5M
Q3 24
$197.2M
$312.7M
Q2 24
$196.0M
$312.3M
Q1 24
$194.2M
$300.4M
Net Profit
CXM
CXM
LFST
LFST
Q4 25
$2.9M
$11.7M
Q3 25
$12.6M
$1.1M
Q2 25
$-1.6M
$-3.8M
Q1 25
$98.7M
$709.0K
Q4 24
$10.5M
$-7.1M
Q3 24
$1.8M
$-6.0M
Q2 24
$10.6M
$-23.3M
Q1 24
$21.1M
$-21.1M
Gross Margin
CXM
CXM
LFST
LFST
Q4 25
66.4%
Q3 25
68.2%
Q2 25
69.5%
Q1 25
71.0%
Q4 24
71.2%
Q3 24
72.6%
Q2 24
73.9%
Q1 24
75.5%
Operating Margin
CXM
CXM
LFST
LFST
Q4 25
5.3%
4.7%
Q3 25
7.7%
2.0%
Q2 25
-0.9%
-0.9%
Q1 25
5.2%
0.5%
Q4 24
3.9%
0.3%
Q3 24
-0.0%
0.0%
Q2 24
2.9%
-5.1%
Q1 24
9.5%
-5.6%
Net Margin
CXM
CXM
LFST
LFST
Q4 25
1.3%
3.1%
Q3 25
5.9%
0.3%
Q2 25
-0.8%
-1.1%
Q1 25
48.7%
0.2%
Q4 24
5.2%
-2.2%
Q3 24
0.9%
-1.9%
Q2 24
5.4%
-7.5%
Q1 24
10.9%
-7.0%
EPS (diluted)
CXM
CXM
LFST
LFST
Q4 25
$0.01
Q3 25
$0.05
Q2 25
$-0.01
Q1 25
$0.35
Q4 24
$0.04
Q3 24
$0.01
Q2 24
$0.04
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$189.6M
$248.6M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$558.1M
$1.5B
Total Assets
$1.1B
$2.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
LFST
LFST
Q4 25
$189.6M
$248.6M
Q3 25
$125.4M
$203.9M
Q2 25
$126.4M
$188.9M
Q1 25
$145.3M
$134.3M
Q4 24
$93.2M
$154.6M
Q3 24
$119.1M
$102.6M
Q2 24
$126.8M
$87.0M
Q1 24
$164.0M
$49.5M
Total Debt
CXM
CXM
LFST
LFST
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
CXM
CXM
LFST
LFST
Q4 25
$558.1M
$1.5B
Q3 25
$543.4M
$1.5B
Q2 25
$639.8M
$1.5B
Q1 25
$612.1M
$1.5B
Q4 24
$497.0M
$1.4B
Q3 24
$469.0M
$1.4B
Q2 24
$610.9M
$1.4B
Q1 24
$679.7M
$1.4B
Total Assets
CXM
CXM
LFST
LFST
Q4 25
$1.1B
$2.2B
Q3 25
$1.1B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$2.1B
Q4 24
$970.3M
$2.1B
Q3 24
$983.8M
$2.1B
Q2 24
$1.1B
$2.1B
Q1 24
$1.2B
$2.1B
Debt / Equity
CXM
CXM
LFST
LFST
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
LFST
LFST
Operating Cash FlowLast quarter
$20.0M
$57.6M
Free Cash FlowOCF − Capex
$19.8M
$46.6M
FCF MarginFCF / Revenue
9.0%
12.2%
Capex IntensityCapex / Revenue
0.1%
2.9%
Cash ConversionOCF / Net Profit
6.87×
4.93×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
LFST
LFST
Q4 25
$20.0M
$57.6M
Q3 25
$34.8M
$27.3M
Q2 25
$83.8M
$64.4M
Q1 25
$5.4M
$-3.1M
Q4 24
$9.2M
$62.3M
Q3 24
$21.3M
$22.7M
Q2 24
$41.7M
$44.1M
Q1 24
$17.3M
$-21.8M
Free Cash Flow
CXM
CXM
LFST
LFST
Q4 25
$19.8M
$46.6M
Q3 25
$34.4M
$17.0M
Q2 25
$83.5M
$56.6M
Q1 25
$4.6M
$-10.3M
Q4 24
$8.2M
$56.0M
Q3 24
$19.8M
$17.7M
Q2 24
$39.2M
$39.0M
Q1 24
$15.2M
$-26.9M
FCF Margin
CXM
CXM
LFST
LFST
Q4 25
9.0%
12.2%
Q3 25
16.2%
4.7%
Q2 25
40.6%
16.4%
Q1 25
2.3%
-3.1%
Q4 24
4.1%
17.2%
Q3 24
10.1%
5.7%
Q2 24
20.0%
12.5%
Q1 24
7.9%
-9.0%
Capex Intensity
CXM
CXM
LFST
LFST
Q4 25
0.1%
2.9%
Q3 25
0.2%
2.8%
Q2 25
0.1%
2.2%
Q1 25
0.4%
2.2%
Q4 24
0.5%
1.9%
Q3 24
0.8%
1.6%
Q2 24
1.3%
1.6%
Q1 24
1.1%
1.7%
Cash Conversion
CXM
CXM
LFST
LFST
Q4 25
6.87×
4.93×
Q3 25
2.76×
25.34×
Q2 25
Q1 25
0.05×
-4.36×
Q4 24
0.88×
Q3 24
11.58×
Q2 24
3.92×
Q1 24
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

LFST
LFST

Segment breakdown not available.

Related Comparisons